Predictors of Late Effects in Young AML Survivors Explored

MONDAY, Nov. 23, 2020 -- Many adolescent and young adult (AYA) survivors of acute myeloid leukemia (AML) experience late effects, with the most common being endocrine, cardiovascular, and respiratory, according to a study published online Nov. 9 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news